Related Experiment Videos
Hormone replacement therapy and coronary heart disease
1Department of Internal Medicine, Kaiser Permanente Medical Center, San Francisco, California.
Obstetrics and Gynecology Clinics of North America
|December 1, 1990
Summary
Postmenopausal hormone replacement therapy, when properly administered with progestogen, is safe and beneficial for managing menopausal symptoms and potentially reducing cardiovascular disease risk. Physician judgment is key to optimizing patient outcomes with evolving therapeutic options.
Area of Science:
- Reproductive Endocrinology
- Cardiovascular Health
- Oncology
Background:
- Postmenopausal hormone replacement therapy (HRT) has a complex history of medical opinion, shifting between endorsement and caution.
- Estrogen's benefits for menopausal symptoms and bone health were initially tempered by concerns over endometrial cancer risk.
- The addition of progestogen has been shown to mitigate the endometrial risks associated with estrogen therapy.
Purpose of the Study:
- To review the evolving evidence and clinical practice surrounding postmenopausal hormone replacement therapy.
- To highlight the cardiovascular benefits of postmenopausal estrogen therapy, particularly coronary heart disease (CHD) risk reduction.
- To emphasize the importance of individualized treatment strategies in HRT prescription.
Main Methods:
- Review of epidemiological and experimental evidence regarding postmenopausal hormone replacement therapy.
- Analysis of the risks and benefits of estrogen therapy, including endometrial and cardiovascular effects.
- Discussion of evolving prescribing practices and patient-specific treatment considerations.
Main Results:
- Evidence suggests significant coronary heart disease (CHD) health benefits from postmenopausal estrogen therapy.
- Progestogen co-therapy is essential for endometrial safety and is considered a reasonable and practical addition.
- Appropriate administration of HRT is considered safe and beneficial, despite potential minor offsets in cardiovascular benefits by progestogen.
Conclusions:
- Hormone replacement therapy, when appropriately administered, offers both safety and significant health benefits for postmenopausal women.
- Physicians must exercise best judgment in selecting patient-specific HRT formulations, dosages, routes, and schedules.
- Continued evolution in prescribing habits, patient selection, and monitoring procedures enhance the appropriate implementation of HRT.